C3 and status epilepticus: C3/C3aR signaling strengthens microglia-astrocyte communication, promotes gliosis, and exacerbates neuronal injury; genetic deletion or pharmacologic depletion of C3 mitigates status-epilepticus-related neurodegeneration and memory deficits in models, highlighting this axis as a tractable target [16].